Research-compound stores are declined by every mainstream aggregator and quoted high-risk rates by everyone else. BrokkrPay is the third option: keep your own Stripe account, and change what reaches it.
BrokkrPay serves lawful SARM and research-compound merchants when approved. It is software, not a merchant account: you keep your own Stripe account, add a Pay with Stripe button to your checkout, and the customer is sent straight to a Stripe Checkout page to pay with Visa, Mastercard, Apple Pay, or Google Pay. BrokkrPay de-risks the transaction and the charge settles on your own Stripe balance, for a flat 2.5% plus Stripe’s standard rate, with no BrokkrPay rolling reserve. Every merchant is underwritten individually.
The boundary matters more in this vertical than in any other, so it is worth stating before anything else.
Every business is screened and underwritten individually, and approval is never guaranteed. How a product is labelled and marketed is usually the deciding factor — the same underwriting logic described in detail on peptide payment processing. This is not legal advice; take advice specific to your jurisdiction and product range.
The BrokkrPay column is published pricing. The merchant-account column is the typical industry range, not a quote from any named provider.
Merchant-account figures are typical industry ranges for a dedicated high-risk MID. Actual pricing, reserve terms, and underwriting timelines vary by acquirer, vertical, and volume.
The full line-by-line contrast is on BrokkrPay vs a high-risk merchant account.
Integration detail is on the developer docs, the full walkthrough on how it works, and pricing on the pricing page. Related verticals: research peptides and supplements & nootropics.
Tell us your vertical and your monthly volume. Approved operators are live on their own Stripe account within a day.